CONTROLLED RELEASE IBUPROFEN NANOPARTICLES: PHYSICO-CHEMICAL CHARACTERIZATION AND DRUG RELEASE

Authors

  • Valerie Sastre School of Pharmacy, University of Puerto Rico, P.O. Box 365067, San Juan, P.R 00936
  • Evone S. Ghaly School of Pharmacy, University of Puerto Rico, P.O. Box 365067, San Juan, P.R 00936

Keywords:

Ibuprofen, Lipid matrix, Solid state, Kinetic release model, Lipid-surfactant nanoparticles, Controlled release

Abstract

Objectives: The effect of lipid phase composition, concentration of lipid and surfactant on the entrapment, morphology, particle size and release profiles of ibuprofen-loaded lipid particles was evaluated.

Methods: Formulations containing only a solid lipid (Compritol® 888 ATO) and formulations containing mixture of solid and liquid lipids (Compritol® 888 ATO: Labrafil® M 1944 CS) were prepared at various lipid level (5%, 10% and 15% w/v) and surfactant (1.35% and 3%w/v) concentrations using the hot homogenization method.

Results: The particle size distribution was found to be polydisperse with a high concentration of microparticles. The particles were spherical in shape. The preparation method was effective in producing particles with high drug entrapment efficiencies (65% – 100%). Drug release studies showed a controlled release profile that follow diffusion kinetic model for all formulations. High lipid concentrations (10% and 15%) increased drug entrapment capacity and showed low initial burst of the drug during early time of testing dissolution. X-Ray diffraction and NMR studies showed coexistence of both amorphous and crystalline forms of the ibuprofen within the lipid matrix. Addition of Labrafil® led to a more amorphous internal structure by modifying the crystallinity of both ibuprofen and the lipid Compritol®.

Conclusions: This investigation solved problems associated with nanoparticles

Downloads

Download data is not yet available.

Author Biography

Valerie Sastre, School of Pharmacy, University of Puerto Rico, P.O. Box 365067, San Juan, P.R 00936

Graduate Student

References

Casadei M, Cerreto F, Cesa S, Grianmuzo M, Feeney M, Marianecci C, Paolicelli P. Solid lipid nanoparticles incorporated in dextran hydrogels. Int J Pharm 2006;140-6.

Barthelemy P, Laforet J, Joachim F. Compritol 888 ATO:an innovative hot melt agent for prolonged release drug formulations. Eur J Pharm Biopharm 1999;87-90.

Umer M, Gornullo U, Yaner G, Altmkurt T. A new approach for preparing controlled release Ketoprofen tablets using beeswax. J Farmaco 2005;27-31.

Das S, Kong W, Tan R. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles ((SLNs):development, characterization and comparative evaluations of clotramazole loaded SLNs and NLCs. Eur J Pharm Sci 2013;139-51.

Garcia-Fuentas M, Alonzo M, Torres D. Design and characterization of a new drug nanocarrier made of solid-liquid lipid mixtures. J Colloid Ibterface Sci 2005;590-6.

Pardelike J, Weber S, Matsko N, Zimmer A. Formation of a physical stable delivery by simply autoclaving nanostructured lipid carriers (NLC). Int J Pharm 2012;22-7.

Cimi M, Bragagni N, Mura P. Development of new delivery system consisting of drug in cyclodextrin nanostructured lipid carriers for Ketoprofen topical delivery. Eur J Pharm Biopharm 2012:46-53.

KheradmandiniaS, Vasheg-Farahani E, Nostrati, MAtyabi F. Characterization of Ketoprofen loaded solid lipid nanoparticles made of beeswax and carnuba wax. J Nanomedicine 2010;753-9.

Martins S, Tho I, Ferreira D, Souto E, Brandl M. Physicochemical properties of lipid nanoparticles. Effect of lipid and surfactant composition. J Drug Dev Ind Pharm 2011;815-24.

Portta S, Minemi S, Nukala R, Peinado C, Lamprou D, Uequhart A, Douroumis D. Preparation and characterization of Ibuprofen solid lipid nanoparticles with enhanced solubility. J Microcapsulation 2011;74-81.

Puglia C, Blasi P, Rizza L, Schoubben A, Bonina F, Rossi C, Rocci M. Lipid nanoparticles for prolonged topical delivery:An in vitro in vivo investigation. Int J Pharm 2008;295-304.

Martins S, Tho I, Ferreira D, Souto E, Brandl M. Multivariance design for the evaluation of lipid and surfactant composition effect for optimization of lipid nanoparticles. Eur J Pharm Sc 20i2;613-23.

Zhang Q, Jiang X, Jiang W, Su L, Shi Z. Preparation of nimodipine loaded microemulsion for intestinal delivery and evaluation on the targeting efficiency to braim. Int J Pharm 2004;85-96.

Basak S, Kumar K, Ramalingram M. Design and release characteristics of Jsustained release tablets containing Metformin hydrochloride. J Brazilian Pharm Sci 2008;477-83.

Jana U, Mohanty AK, PAL SL, Manna PK, Mohanta GP. Preparation and In vitro characterization of felodipine loaded Eudragit RS 100 nanoparticles. Int J Pharm Pharm Sci 2014;564-7.

Published

31-08-2014

How to Cite

Sastre, V., and E. S. Ghaly. “CONTROLLED RELEASE IBUPROFEN NANOPARTICLES: PHYSICO-CHEMICAL CHARACTERIZATION AND DRUG RELEASE”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 6, no. 8, Aug. 2014, pp. 99-107, https://innovareacademics.in/journals/index.php/ijpps/article/view/1329.

Issue

Section

Original Article(s)